| Disaster Research Response Network (DR2) |
Committee, Work group, Advisory group, or Task Force |
CDC |
FIC, NCI, NIA, NIAID, NIEHS, NINDS |
The DR2 Program provides training, funding, and a Resources Portal of tools to empower human health research in response to disasters and public health emergencies. |
| DOD Congressionally Directed Medical Research Programs (CDMRP) Autism Research Programmatic Panel |
Committee, Work group, Advisory group, or Task Force |
CDC |
NINDS |
The CDMRP Autism Research Programmatic Panel aims to advance the understanding, diagnosis, and treatment of Autism through its award mechanisms, programs, and funding recommendations. |
| DRCR Retina Network |
Research Initiative |
OS |
NEI, NIDDK |
The DRCR Retina Network (formerly known as the Diabetic Retinopathy Clinical Research Network) (DRCR.net) is a collaborative network dedicated to facilitating multicenter clinical research of diabetic retinopathy, diabetic macular edema, and associated conditions. The DRCR.net supports the identification, design, and implementation of multicenter clinical research initiatives focused on diabetes-induced retinal disorders. Principal emphasis is placed on clinical trials, but epidemiologic outcomes and other research may be supported as well. The network is funded by the National Eye Institute (NEI), and co-funded by the Office of the Secretary (OS), through National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), with the Special Funding Program for Type 1 Diabetes Research. |
| Drug Development Interest Group |
Committee, Work group, Advisory group, or Task Force |
ASPR |
NHLBI, NIAID |
DDIG is a NIAID team that promotes knowledge sharing and discussions on drug development, technological platforms and models for the discovery and development of antiinfectives having different chemical structures and modalities (e.g. small molecule-, peptide-, natural product-based inhibitors, antibodies, targeted degradation, live microbes). The team aims to identify gaps and opportunities to advance translational and clinical research for treatment of bacterial, viral, fungal and parasitic infections, particularly those cause by antibiotic resistant pathogens and viruses of pandemic potential |
| Drug Induced Liver Injury Network |
Resource Development |
FDA |
NCI, NIDDK |
Both a prospective and retrospective database containing cases of drug-induced liver disease, the Drug-Induced Liver Injury Network (DILIN) is funded by a cooperative agreement and includes eight clinical centers and a central data coordinating center. Established by NIDDK, one of the goals of the DILIN is to establish a database of well-characterized cases of drug-induced liver injury along with serum, DNA, and tissue samples that will facilitate research on the mechanisms of hepatic injury due to drugs. Cases of liver injury due to herbal medications are also included. The DILIN will develop standardized definitions of drug-induced liver disease and standardization of scoring systems for causality. Employees of the Food and Drug Administration (FDA) serve as ad hoc members on the committee overseeing the network activities. |
| DURC/PEPP Policy Implementation Working Group |
Health Survey |
ASPR, CDC, FDA |
OD/OSP |
Interagecy Working Group to develop processes and guidance and oversee effective and consistent USG-wide implementation of the U.S. Government Policy for Oversight of Dual Use Research of Concern (DURC) and Pathogens with Enhanced Pandemic Potential (PEPP). |
| Early Hearing Detection and Intervention Working Group |
Committee, Work group, Advisory group, or Task Force |
HRSA, CDC |
NIDCD |
HRSA-led intra-agency collaborative focused on oversight and implemetation of the federal EHDI program |
| Ebola Clinical Research Response in Democratic Republic of the Congo |
Research Initiative |
ASPR, CDC |
NIAID |
Multi-lateral collaborative partnerships including, but not limited to National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and host countries Ministries of Health. Research focus includes Ebola and other emerging and re-emerging infectious diseases. These programs are capable of rapidly mounting a clinical research response. |
| Ebola Research Agenda Working Group |
Committee, Work group, Advisory group, or Task Force |
ASPR, CDC, FDA |
NIAID |
Working group to establish a research agenda for Ebola virus. |
| ECHO Institute and Project ECHO for Cancer Research and Control |
Other |
CDC |
NCI |
The mission of Project ECHO (Extension for Community Healthcare Outcomes) at the University of New Mexico Health Sciences Center (UNMHSC) is to demonopolize knowledge and amplify the capacity to provide best practice care for underserved people all over the world. In pursuit of this mission, Project ECHO® faculty, staff and partners have dedicated themselves to de-monopolizing knowledge in order to expand access to best-practice medical care across the United States and globally. The ECHO model utilizes a technology-enabled case-based knowledge exchange approach. The NCI/CGH through partnership with the ECHO Institute utilizes the ECHO model to convene global cancer research and control networks to exchange knowledge to advance the uptake of evidence-based interventions to advance cancer control and build research partnerships. Project Extension for Community Healthcare Outcomes (ECHO) is a collaborative medical education model that aims to build workforce and knowledge capacity, through use of online videoconferencing to allow for knowledge exchange across interdisciplinary teams on relevant medical, healthcare, and health systems related topics. The National Cancer Institute (NCI) Center for Global Health (CGH) Project Echo Cancer Control Planning Program will link participants active in cancer control planning in low- and middle-income country settings with researchers, regional colleagues, and relevant technical experts, through monthly ECHO sessions that will provide virtual didactic instruction, case study learning, and knowledge exchange on relevant evidence-based cancer control planning principles. These sessions will relay evidence-based, general cancer control principals and related to cervical cancer screening. The CGH Project ECHO program’s primary goals are to increase participant knowledge of the aforementioned topics, improve the application of knowledge, including evidence-based practices and policies, and to increase collaboration among participants and experts who are active in cancer control planning in the participating countries. |